Last reviewed · How we verify

NCT07343258: CONT-1813

Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline

Recruiting now NA Last updated 19 February 2026
What this trial tests

NA trial testing Callbacks from the Zelfmoordlijn 1813 in Suicide in 98 participants. Currently enrolling.

Timeline
5 January 2026
Primary endpoint
30 September 2026
30 September 2026

Quick facts

Lead sponsorUniversity Ghent
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment98
Start date5 January 2026
Primary completion30 September 2026
Estimated completion30 September 2026
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Ghent

Who can join

18 and older, any sex, with Suicide or Suicidal Ideation and Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study aims to assess the acceptance, feasibility, and added value of follow-up calls at the suicide helpline, Zelfmoordlijn 1813, in Flanders (Belgium). It serves as a crucial preparatory step in the development and implementation process of the callback methodology at Zelfmoordlijn 1813.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other University Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07343258.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing